11:07 AM EST, 12/26/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts were slightly higher late Thursday morning, edging 0.10% higher to 1,298.82 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by furniture maker Natuzzi (NTZ) and medical device maker EDAP TMS ( EDAP ) , which climbed 18% and 7.3% respectively. They were followed by telecommunications company VEON (VEON) and biopharmaceutical company Genfit ( GNFT ) , which were up 2.5% each.

The decliners from continental Europe were led by biotech firm Evaxion Biotech ( EVAX ) and biopharmaceutical company DBV Technologies ( DBVT ) , which dropped 2.8% and 2.6% respectively. They were followed by accommodations booking company trivago (TRVG) and 3D printer company Materialise (MTLS), which were off 0.7% each.

From the UK and Ireland, the gainers were led by biotech firm Autolus Therapeutics ( AUTL ) and biopharmaceutical company Verona Pharma ( VRNA ) , which increased 2.2% and 2% respectively. They were followed by biopharmaceutical companies Bicycle Therapeutics ( BCYC ) and TC Biopharm ( TCBP ) , which rose 1.8% and 1% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company Adaptimmune Therapeutics ( ADAP ) and biotech firm Trinity Biotech ( TRIB ) , which dropped 3.8% and 3% respectively. They were followed by biopharmaceutical company Akari Therapeutics ( AKTX ) and pharmaceutical company Silence Therapeutics ( SLN ) , which lost 1.6% and 1.5% respectively.